Background: Some lines of mice homozygous for a disrupted prion protein gene (Prnp), including Ngsk Prnp
Introduction
The cellular isoform of prion protein (PrP C ), a membrane glycoprotein anchored by a glycosylphosphatidylinositol moiety, is highly expressed in the central nervous system (CNS), in particular on neurons. PrP C is known to play a crucial role in the pathogenesis of prion diseases (1,2), but its physiological function remains to be clarified. We previously reported a line of PrP C -deficient mice, designated Ngsk Prnp 0/0 mice, that exhibited ataxia due to cerebellar Purkinje cell degeneration and demyelination in the spinal cord and peripheral nervous system at old age (3, 4) . Subsequently, two other independent mouse lines, Rcm0 and Zrch II Prnp 0/0 mice, were confirmed to develop similar neurodegeneration (5, 6) . In contrast, another independent line, Zrch I Prnp 0/0 , revealed the demyelination and has never exhibited Purkinje cell degeneration (4) . Behavioral and electrophysiological studies of the Zrch I Prnp 0/0 mice demonstrated abnormal circadian rhythms (7) and impaired long-term potentiation in the hippocampus (8) , respectively. In spite of the discrepancy in the ataxic phenotype, all of the neurological abnormalities, including the Purkinje cell degeneration in these PrP C -deficient mice were subsequently rescued by the introduction of a transgene encoding wild-type PrP C (4, 7, 9) , indicating the crucial role of PrP C in survival and various functions of neurons.
Others and we recently identified a novel gene, Prnd, that is localized 16 kb downstream of the murine PrP gene (Prnp) and encodes a PrP-like protein, PrPLP/Dpl (5, 10) . This novel membrane glycoprotein is homologous to the C-terminal two-thirds of PrP with a 23% identity in the amino acid sequence. Interestingly, in the brains of Ngsk, Rcm0, and Zrch II Prnp 0/0 mice, but not in those of Zrch I Prnp 0/0 mice, unusual intergenic splicing between Prnp and Prnd occurred as a result of the deletion of a part of the Prnp intron 2 sequence, including its splicing acceptor (5,10). As a consequence, the PrPLP/Dpl was ectopically expressed in neurons, under the control of the Prnp promoter (10) 
Materials and Methods

Mice
Ngsk Prnp 0/0 mice were generated as described previously (2 
Northern Blot Analysis
Total RNA was extracted using Trizol reagent (Gibco BRL Life Technologies, Inc., Grand Island, NY, USA), separated on a formaldehyde-denatured agarose gel, and blotted onto a Hybond N membrane (Amersham Pharmacia Biotech, Buckinghamshire, UK) with 10 ϫ SSC. The RNA was fixed onto the membrane by ultraviolet light at 70,000 microjoules per cm 2 for 2 min (UVP, Ltd., Upland, USA). Next, the membrane was subjected to a prehybridization procedure for 4 hr at 45ЊC in the buffer (5 ϫ SSPE/0.5% SDS/50% formamide/5 ϫ Denhardt's solution/10% dextran sulphate/100g/ml salmon sperm DNA), and then hybridized using an appropriate 32 P-labelled DNA probe (BcaBEST Labelling Kit, TaKaRa, Tokyo, Japan) overnight at 45ЊC in the same buffer. The membrane was washed twice in 2 ϫ SSC/0.1% SDS at room temperature for 10 min, once in 1 ϫ SSC/0.1% SDS, and twice in 0.1 ϫ SSC/0.1% SDS at 65ЊC for 15 min. Signals were detected by BAS 5000 (Fuji, Tokyo, Japan) or autoradiography on Konica X-ray film.
In Situ Hybridization
Brains were fixed for 16 hr in 4% buffered-paraformaldehyde (pH 7.4) at 4ЊC, embedded in paraffin and sliced to 5-m thickness. The sections were deparaffinized, digested with 8 mg/ml pepsin and 10 mg/ml proteinase K for 10 min at 37ЊC, and soaked for 10 min in 0.25% acetic anhydride/0.1 mM triethanolamine hydrochloride (pH 8.0)/0.9% NaCl. The cRNA probes were labelled with digoxigenin (DIG)-UTP (Roche Diagnostics, Mannheim, Germany) using T7 or T3 polymerase (Gibco BRL Life Technologies, Inc.). The tissue sections were subjected to hybridization with the labelled cRNA probes in buffer (50% formamide/10 mM Tris-HCl [pH 7.5]/1 mM EDTA/0.6M NaCl/0.5 mg/ml yeast tRNA/0.25 mg/ml salmon sperm DNA/1% skim milk/0.25% SDS/5 ϫ Denhart's solution) at 50ЊC for 16 hr. The sections were washed several times in 4 ϫ SSC, and immersed in 50% formamide/2 ϫ SSC at 50ЊC for 30 min. They were digested by 20 g/ml RNase A at 37ЊC for 30 min and washed in 0.2 ϫ SSC at 60ЊC for 20 min. Signals were detected by an enzyme-linked immunosorbent assay using alkaline phosphatase conjugated anti-DIG Fab fragments (1:500, Roche Diagnostics) and nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate (NBT/BCIP).
Probes
The LM probe used has been described previously (12) 
Immunohistochemistry
Deparaffinized sections were digested with 1 mg/ml trypsin for 15 min at 37ЊC, and then placed in 3% H 2 O 2 in methanol for 30 min at room temperature to abolish endogenous peroxidase activity. After treatment with normal rabbit serum for 30 min, the tissue sections were incubated overnight at 4ЊC with anti-GFAP ( 
Results
Upregulation of Glial Cell-specific Gene Expression in the Brains of Aged Ngsk Prnp 0/0 Mice
We first examined expression levels of the glial fibrillary acidic protein (GFAP) and lysozyme M (LM) mRNAs specific to astrocytes and microglia, respectively, in the forebrains and cerebella of 102-week-old Ngsk Prnp 0/0 mice. Total RNA isolated from the pooled forebrains and cerebella of Ngsk Prnp 0/0 and age-matched wild-type (Prnp ϩ/ϩ ) mice was subjected to Northern blotting. As shown in Fig. 1a , the GFAP and LM mRNA levels were elevated in both tissue types in the Ngsk Prnp 0/0 mice. Densitometric analysis estimated that, compared with those of the Prnp ϩ/ϩ mice, GFAP mRNA was increased 2.5-and 2.7-times, and LM mRNA 2.7-and 3.0-times, in the forebrains and cerebella, respectively. In contrast, the expression of inositol 1,4,5-trisphosphate receptor type 1 (IP 3 R1) mRNA, a specific marker for Purkinje cells, was decreased in the cerebella of Ngsk Prnp 0/0 mice (Fig. 1a) . In situ hybridization and immunohistochemistry on the brain sections of Ngsk Prnp 0/0 mice at 92 weeks of age revealed numerous astrocytes expressing GFAP mRNA and its product mainly in the major white matter areas including the corpus callosum, fimbria hippocampus, and internal and external capsula, and the cerebellum (Fig. 2) . While a number of astrocytes was also seen in the brain tissues of the age-matched and Prnp ϩ/ϩ mice were subjected to Northern blotting using appropriate probes. The GFAP, LM, and IP 3 R1 probes were used in (a) and synaptophysin (Syn), MBP, and PLP probes in (b). The integrity and quantity of RNA were verified with a glyceraldehydes-3-phosphate dehydrogenase (GAPDH) probe on the same membrane. extracted from the pooled forebrains and cerebella of 102-week-old Ngsk Prnp 0/0 mice. Similarly to the IP 3 Rl mRNA, the expression of synaptophysin was normal in the forebrains but reduced in the cerebella of 102-week-old Ngsk Prnp 0/0 mice (Fig. 1b) . On the other hand, there was no difference in the levels of MBP and PLP mRNAs between Ngsk Prnp 0/0 and agematched Prnp ϩ/ϩ mice. These observations were also confirmed by in situ hybridization (data not shown).
Glial-cell Activation Occurs Well Before the Onset of Purkinje Cell Degeneration in the Brains of Ngsk Prnp 0/0 Mice
We monitored kinetics of the GFAP and LM mRNA levels in the pooled forebrains and cerebella of Ngsk Prnp 0/0 and wild-type mice at various ages between 3 and 102 weeks. In the Ngsk Prnp 0/0 mice, however, increased levels of GFAP mRNA appeared as early as 8 and 3 weeks in the forebrains and cerebella, respectively, and the transcript accumulated more rapidly in the tissues (Fig. 3a, b) . Increased levels of LM mRNA were also seen from 22 and 8 weeks in 
Discussion
In the present study, we demonstrated glial-cell activation, or gliosis, with the upregulated expression of both astrocyte-and microglia-specific genes encoding GFAP and LM, respectively, in the brains of Ngsk Prnp 0/0 mice. A transgene for wild-type PrP C rescued the forebrains and cerebella, respectively, and levels continued to rise until 102 weeks. In contrast, the decline of IP 3 R1 mRNA in the cerebella of Ngsk Prnp 0/0 mice became evident at 36 weeks, suggesting that glial-cell activation occurs before the onset of the Purkinje cell degeneration. (Fig. 4a, b) . Additionally, the number of astrocytes and microglia in the Tg(P) Ngsk Prnp 0/0 mice was decreased to the level seen in the Prnp ϩ/ϩ mice, as shown by in situ hybridization and immunohistochemistry (Fig. 2) .
A Transgene Encoding Wild-type PrP
The Level of Glial-cell Activation Correlates with that of Ectopic Expression of PrPLP/Dpl
To further elucidate the mechanisms for the glial-cell activation, we examined the expression levels of (Fig. 5a ). The expression levels of GFAP and LM mRNAs correlated well with that of PrPLP/DpL mRNA. The Zrch I Prnp 0/0 mice aged 70 weeks showed no upregulation of the GFAP and LM mRNAs, exhibiting levels similar to those of agematched Prnp ϩ/ϩ mice (Fig. 5a, b) . The Ngsk/Zrch I Prnp 0/0 mice exhibited levels of GFAP and LM mRNAs between those of the Ngsk Prnp 0/0 and Prnp ϩ/ϩ mice (Fig. 5a, b) . Another intriguing possibility is a direct effect of the ectopic PrPLP/Dpl on the glial cells in the absence of PrP C . Activated astrocytes and microglia were distributed throughout the forebrains and cerebella of aged Ngsk Prnp 0/0 mice, mainly in the white matter. However, there was no histological evidence for neurodegeneration or demyelination other than the Purkinje cell degeneration. In contrast to the reduced levels of IP 3 R1 and synaptophysin mRNAs in the cerebellum, representing the Purkinje cell degeneration, the synaptophysin mRNA level in the forebrain appeared to be normal. Transcripts for two major myelin components, MBP and PLP, were expressed at normal levels in both the forebrain and cerebellum. The expression profiles of these genes argues against the presence of submicroscopic neuronal injury other than the Purkinje cell degeneration. Moreover, a kinetic analysis demonstrated glialcell activation well before the onset of Purkinje cell degeneration in the Ngsk Prnp 0/0 mice. It is thus conceivable that the glial-cell activation is primarily induced by the ectopic PrPLP/Dpl in the absence of PrP C rather than as a consequence of neuronal injury. Astrocytes were reported to physiologically express PrP mRNA in vivo (20) . We detected abundant PrPLP/Dpl mRNA in the primary culture of astrocytes derived from the Ngsk Prnp 0/0 mice (data not shown). The ectopic PrPLP/Dpl on the surface of glial cells in the absence of PrP C may be the cause of the abnormal cell activation. An alternative possibility is that PrP C on the surface of neurons may be involved in the communication with glial cells, and the loss of PrP C together with ectopic PrPLP/Dpl on the neuronal surface may result in the glial-cell activation. Targeted expression of PrP C in either glial cells or neurons of Ngsk Prnp 0/0 mice would be useful to elucidate mechanisms of the glial-cell activation.
It is noteworthy that not only astrocytes but also microglia were activated in the brains of Ngsk Prnp 0/0 mice. Activated microglia are thought to be involved in the etiology of various neurodegenerative conditions by their production of neurotoxic substances (21) (22) (23) . For instance, we recently demonstrated that microglial production of lysosomal hydrolases, a perforin-like protein, and reactive oxygen species was closely correlated with the onset and progression of pathological changes in an experimental prion disease (12) . The decreased expression of IP 3 R1 mRNA was evident well after the activation of LM gene, suggesting that the activated microglia might play a role in the Purkinje cell degeneration in Ngsk Prnp 0/0 mice. The elucidation of the mechanisms of the glialcell activation in Ngsk Prnp 0/0 mice might provide insights into the understanding of not only the physiological functions of PrP C and PrPLP/Dpl but also the pathogenesis of neurodegenerative disorders, including prion diseases.
